Статья

Regarding the evidence-based use of micronized progesterone

A. Makatsariya, G. Renzo, G. Rizzo,
2021

An issue of habitual miscarriage poses a high social importance especially during COVID-19 pandemic. Meanwhile, healthcare workers faced a mass media campaign against using micronized progesterone upon habitual miscarriage, which, as viewed by publication authors, displays signs of prejudiced data manipulation and may disorient practitioners. Authors of published letter provide objective information on accumulated data regarding gestagens efficacy and safety. They invoke healthcare professionals to make decisions deserving independent primary source trust presented by original scientific papers published in peer-reviewed journals, clinical recommendations proposed by professional medical communities as well as treatment standards and protocols. © 2020 Trylyst. All rights reserved.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • A. Makatsariya
    Head of Department of Obstetrics and Gynecology, N.F. Filatov Clinical Institute of Children's Health, Sechenov University, Moscow, Russian Federation
  • G. Renzo
    Department of Obstetrics and Gynecology, Center for Prenatal and Reproductive Medicine, Sechenov University, Moscow, Russian Federation
  • G. Rizzo
    Department of Obstetrics and Gynecology, N.F. Filatov Clinical Institute of Children's Health, Sechenov University, Moscow, Russian Federation
Название журнала
  • Reproductive Endocrinology
Выпуск
  • 55
Страницы
  • 105-107
Ключевые слова
  • progesterone; Article; coronavirus disease 2019; health care personnel; human; mass medium; pandemic; spontaneous abortion
Издатель
  • LTD Trilist
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus